ClinicalTrials.govpublic full text
Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis
rheumatoid arthritis, rituximab, pharmacokinetics, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810440
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.